Exelixis
EXEL
#1551
Rank
HK$111.55 B
Marketcap
HK$450.20
Share price
0.86%
Change (1 day)
48.33%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company